WeVote
Log In

Bill

Bill

S 7379

Places kratom on the schedules of controlled substances

2025 Regular Session Introduced by Patricia Canzoneri-Fitzpatrick and 2 co-sponsors

S 7379 - Places kratom on the schedules of controlled substances OverviewBill Number: S 7379 Title: Places kratom on the schedules of controlled substancesStatus: REFERRED TO HEAL

REFERRED TO HEALTH
0
WeVote Research Nonpartisan
Bill Summary · S 7379

S 7379 - Places kratom on the schedules of controlled substances

Overview

Bill Number: S 7379
Title: Places kratom on the schedules of controlled substances
Status: REFERRED TO HEALTH
Introduced: April 11, 2025

Purpose and Intent

This bill seeks to classify the herbal supplement kratom as a controlled substance under federal law. The primary intent is to restrict access and regulate the sale and use of kratom, which proponents argue has potential for abuse and public health risks. Supporters of the bill contend that scheduling kratom will help curb its misuse and associated harms.

Key Provisions

  • Adds kratom and its active compounds (mitragynine and 7-hydroxymitragynine) to Schedule I of the Controlled Substances Act
  • Prohibits the manufacture, distribution, dispensation, or possession of kratom except for authorized research and medical purposes
  • Imposes criminal penalties for violations, including fines and imprisonment
  • Directs the Department of Health and Human Services to conduct further research on the public health impacts of kratom

Affected Parties and Impacts

  • Individuals who currently use kratom for its stimulant and opioid-like effects would be criminalized for possession
  • Businesses that manufacture, distribute, or sell kratom products would be forced to cease operations or face legal consequences
  • Public health researchers may face new restrictions on studying the potential benefits and risks of kratom
  • Consumers would lose access to kratom, which some use as an alternative to prescription opioids or to manage chronic pain, anxiety, and other conditions

Procedural and Timeline Considerations

The bill has been referred to the Senate Committee on Health, Education, Labor, and Pensions for further consideration. If reported favorably by the committee, it would then proceed to a full Senate vote. Given the ongoing debate around the regulation of kratom, the bill's prospects for passage remain uncertain at this stage.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.